Sector Chart Eloxx Pharmaceuticals, Inc.

Equities

ELOX

US29014R2022

Delayed OTC Markets 13:26:05 2024-06-28 EDT 5-day change 1st Jan Change
0.69 USD -.--% Intraday chart for Eloxx Pharmaceuticals, Inc. -1.43% -42.50%
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
2.28M - - - - -
121B
113B
26.02B -
19.39B -
15.91B